Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | ELOVL1 | Q9BW60 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.35 |
| ▸ | TYK2 | P29597 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.33 |
| ▸ | ADK | P55263 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9685872 | 0.82 | NPC1 (0.39) | NPC1CYP1A2CYP2D6ALDH1A1CYP3A4 | |
| SCHEMBL7717522 | 0.82 | CYP1A2 (0.50) | CYP1A2CYP2D6ALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL16665315 | 0.77 | FGFR4 (0.37) | NPC1SLC6A2FGFR4 | |
| SCHEMBL17369262 | 0.76 | SLC6A2 (0.35) | NPC1KMT2AMEN1SLC6A2FGFR4 | |
| SCHEMBL2580115 | 0.76 | JAK3 (0.51) | NPC1KMT2AMEN1JAK2 | |
| SCHEMBL1911817 | 0.76 | FGFR4 (0.39) | NPC1ALDH1A1CYP3A4CYP2C19SLC6A2 | |
| SCHEMBL5883439 | 0.74 | POLB (0.46) | NPC1ALDH1A1HSD17B10SLC6A2MAPK1 | |
| SCHEMBL8537152 | 0.74 | SLC6A2 (0.41) | NPC1SLC6A2FGFR4 | |
| SCHEMBL414257 | 0.74 | CSF1R (0.48) | NPC1SLC6A2 | |
| SCHEMBL1671084 | 0.73 | CYP1A2 (0.48) | CYP1A2CYP2D6ALDH1A1CYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116102700-B | Softening agent and preparation method thereof | 江苏奥斯佳材料科技股份有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-116285775-A | High-performance chloroprene rubber adhesive and preparation method thereof | 上谷新材料(苏州)有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-116102700-A | Softening agent and preparation method thereof | 江苏奥斯佳材料科技股份有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-113929891-B | High-strength liquid crystal polymer film, preparation method thereof and special production equipment | 宁波聚嘉新材料科技有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-112961303-B | Softening agent for soft polyurethane foam and application thereof | 江苏奥斯佳材料科技股份有限公司 | 2023-01-03 | — | — | CN | claimed |
| CN-113929891-A | High-strength liquid crystal polymer film, preparation method thereof and special production equipment | 宁波聚嘉新材料科技有限公司 | 2022-01-14 | — | — | CN | claimed |
| EP-3241856-B1 | POLYURETHANE CATALYST AND APPLICATION THEREOF | JIANGSU OSIC PERFORMANCE MAT CO LTD (CN) | 2021-08-18 | — | — | EP | claimed |
| CN-112961303-A | Softening agent for soft polyurethane foam and application thereof | 江苏奥斯佳材料科技股份有限公司 | 2021-06-15 | — | — | CN | claimed |
| CN-112940212-A | Polyurethane catalyst, automotive polyurethane material and preparation method thereof | 江苏奥斯佳材料科技股份有限公司 | 2021-06-11 | — | — | CN | claimed |
| US-10889681-B2 | Polyurethane catalyst and application thereof | JIANGSU OSIC PERFORMANCE MATERIALS CO. LTD. (CN) | 2021-01-12 | — | — | US | claimed |
| US-20180273671-A1 | POLYURETHANE CATALYST AND APPLICATION THEREOF | JIANGSU OSIC PERFORMANCE MATERIALS CO. LTD. (CN) | 2018-09-27 | — | — | US | claimed |
| EP-3241856-A1 | POLYURETHANE CATALYST AND APPLICATION THEREOF | Jiangsu Osic Performance Materials Co. Ltd. (CN) | 2017-11-08 | — | — | EP | claimed |
| US-20260028365-A1 | TYROSINE KINASE 2 INHIBITORS AND USES THEREOF | BIOGEN MA INC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12390463-B2 | Dosage forms and regimens for amino acid compounds | PLIANT THERAPEUTICS, INC. (US) | 2025-08-19 | — | — | US | disclosed |
| US-12378254-B2 | Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2025-08-05 | — | — | US | disclosed |
| US-20250223288-A1 | AMINO ACID COMPOUNDS AND METHODS OF USE | PLIANT THERAPEUTICS, INC. | 2025-07-10 | — | — | US | disclosed |
| EP-1730122-A2 | PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2006-12-13 | — | — | EP | disclosed |
| WO-2005095357-A2 | PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2005-10-13 | — | — | WO | disclosed |
| US-4256738-A | BACTERICIDES, PYRIMIDINYL, QUINAZOLINYL | BOEHRINGER INGELHEIM GMBH (DE) | 1981-03-17 | — | — | US | disclosed |
| US-4084053-A | YELLOW AND ORANGE DYES, PYRIMIDINO(4',5':5,6)-1,2,4-TRIAZINO(4,3-BETA)INDAZOLES | CIBA-GEIGY CORPORATION (US) | 1978-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12390463-B2 | Dosage forms and regimens for amino acid compounds | ITGB6, ITGA6, ITGAV | NPC1 2892/4885CYP1A2 3905/4885CYP2D6 1900/4885 |
| US-20250223288-A1 | AMINO ACID COMPOUNDS AND METHODS OF USE | ITGB6, ITGA6, ITGA5 | NPC1 3297/4885CYP1A2 4533/4885CYP2D6 3537/4885 |
| US-12378254-B2 | Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators | HCRTR2, HCRTR1, OXTR | NPC1 1202/4885CYP1A2 2758/4885CYP2D6 2332/4885 |
| US-20260028365-A1 | TYROSINE KINASE 2 INHIBITORS AND USES THEREOF | TYK2, ERBB2, ROS1 | NPC1 3166/4885CYP1A2 1665/4885CYP2D6 823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.